A cup of coffee can mean many things: a daily part of our routine, a moment of calm, a midday boost. But zoom in past the steam, past the roasted aromatics, down to the caffeine molecule itself, and a different story emerges. At the Texas A&M Health Institute of Biosciences and Technology, researchers have turned this everyday stimulant into something far more unexpected: a molecular “pause button” for engineered cells. In a study published in the Journal of the American Chemical Society (JACS), the team unveiled CODS, a caffeine‑operated dissociation system built using AI‑guided de novo protein design. The paper, “AI‑Guided De Novo Design of a Caffeine‑Induced Protein Dissociation System,” describes how the group reprogrammed “an existing caffeine-responsive chemically induced proximity (CIP) module into a ligand-dependent dissociation system.” “AI is changing how we design biology,” said senior author Yubin Zhou, MD, PhD. “Instead of relying only on protein parts that already exist in nature, we can now design new mini proteins with specific behaviors. Here, we used AI to help turn caffeine into a precise trigger for controlling engineered cells.” A team of Texas A&M Health researchers led by Yubin Zhou, MD, PhD, is using caffeine to precisely control engineered cells, a step toward safer and more responsive therapies. [Texas A&M University]The CODS system pairs a caffeine‑binding protein with a synthetic mini‑binder designed using the BindCraft platform. In the absence of caffeine, the two components stay locked together. Add caffeine, and the complex snaps apart, releasing the binder and shutting…
